Bo Xu

Bo Xu

Interventional cardiologist / Cardiologist
Fuwai Hospital, Chinese Academy of Medical Sciences - Beijing, China

Latest contributions

Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent, and VitaFlow valve

18 May 2022 – From EuroPCR 2022

The objective of this EuroPCR 2022 session is to highlight MicroPort's innovation portfolio in 3 different fields: learn more about the clinical performance of Firehawk Family stent in STEMI patients evaluated by imaging tools, the features and benefits of PCI robot R-ONE and first clinical trial updates in China,...

Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent and VitaFlow valve

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR

17 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in coronary physiology! Angiography-derived coronary microcirculatory assessment in INOCA patients, Heart Team decision-making based on angiography-derived FFR: DECISION QFR, and safety and efficacy of post-PCI physiological assessment: PROPHET-FFR.

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR

EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in BRS/BVS:

  • Magnesium-based Bioresorbable Scaffold in STEMI: 2 years results
  • France Absorb registry: final five years follow-up
  • A randomized trial of thinner-strut sirolimus-eluting BRS in de novo lesions
  • Three-year follow-up of the prospective bvs stemi strategy-it study
  • Final five-year results of AIDA trial
  • Bioresorbable...
EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22

Antegrade CTO PCI with wire escalation - Session with LIVE demonstration

20 May 2021 – From EuroPCR 2021

Watch this session if you want to discuss how to plan and guide a CTO PCI, to learn how to select the most appropriate wires and microcatheters, and to appraise how to apply antegrade and retrograde techniques in a structured manner.

This session was originally presented during...

Antegrade CTO PCI with wire escalation

Bi-directional approach in a complex CTO - Session with LIVE demonstration

20 May 2021 – From EuroPCR 2021

Watch this session if you want to discuss how to plan and guide a CTO PCI, to learn how to select the most appropriate wires and microcatheters and to appraise how to apply antegrade and retrograde techniques in a structured manner.

This session was originally presented during...

Bi-directional approach in a complex CTO

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 1)

19 May 2021 – From EuroPCR 2021

Watch this session if you want to understand the role of invasive physiology in planning, guiding and evaluating your PCI strategy in MVD, to appreciate the role of intravascular imaging in the optimisation of PCI in such patients and to explore the expanding role of CT...

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 1)

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 2)

19 May 2021 – From EuroPCR 2021

Watch this session if you want to understand the role of invasive physiology in planning, guiding and evaluating your PCI strategy in MVD, to appreciate the role of intravascular imaging in the optimisation of PCI in such patients and to explore the expanding role of CT...

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 2)

One-year results from the FUTURE-II trial

19 May 2021 – From EuroPCR 2021

This LBT session, which was originally presented during EuroPCR 2021, deals with the FUTURE-II study on the new generation of bioresorbable scaffolds, providing comparative safety and efficacy evidence of the thinner-strut PLLA-based BRS in the treatment of patients with noncomplex coronary lesions.

One-year results from the FUTURE-II trial

Leading with evidence, latest clinical outcomes update for Firesorb, Firehawk and VitaFlow

19 May 2021 – From EuroPCR 2021

Watch this session presented by Alexandra Lansky, Andreas Baumbauch, Junbo Ge and Bo Xu in order to learn about the one-year results from a pivotal RCT (FUTURE II), the four-year results from TARGET AC, and the four-year results from VitaFlow transcatheter aortic valve system in patients with severe aortic...

Leading with evidence, latest clinical outcomes update for Firesorb, Firehawk and VitaFlow